The new WHO Preferred Product Characteristics for New Tuberculosis Vaccines draft document is now available online for public review and comment.
The World Health Organization (WHO) has engaged into the development of new TB vaccines Preferred Product Characteristics (PPCs). PPCs are official WHO guidance documents that describe WHO preferences for parameters of vaccines, in particular their indications, target groups, possible immunization strategies, and features of clinical data desired related to safety and efficacy, supportive of policy decision making. The primary target audience for the PPC is any entity intending to eventually seek WHO policy recommendations and prequalification for their products, required for procurement by UN agencies. Vaccine PPCs are built through a wide consensus building process and result from interactions with a variety of stakeholders.
Reviewers are kindly requested to relay comments via the provided Comment Review Form by 15 February 2018. Completed forms should be directed to: Dr. Johan Vekemans, Medical Officer, WHO IVB/IVR, E-mail: firstname.lastname@example.org